Thermo Fisher Scientific Buys Open Biosystems, Creating Unmatched RNAi Platform
More News related to TMO
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, October 23, 2008
- Applied Biosystems, Amaxa, and Invitrogen Lead Attractive Gene Silencing Market - Revealed in New Life Science Dashboard(TM) Market Research Report
- Thermo Fisher Scientific Demonstrates Leading Technologies for Food Safety at AOAC
- Thermo Fisher Scientific Ships First Product With InforSense Virtual Machine Inside
- Thermo Fisher (TMO) Authorizes $500M Buyback
More News related to Mergers and Acquisitions
- Banco Santander, S.A. (STD) to Acquire Sovereign Bancorp (SOV)
- QCR Holdings (QCRH) to Sell First Wisconsin Bank & Trust for $13.5M
- Diebold (DBD) Comments on Withdrawal of Bid From United Technologies (UTX); Increases FY08 EPS Guidance
- Telefonica S.A. (TEF) Increases Offer to Acquire Compania de Telecomunicaciones de Chile
- Wells Fargo (WFC) Insurance Services Acquires EMAR Group
Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, announced that it has acquired Open Biosystems, Inc., a provider of RNA interference (RNAi), gene expression and protein detection products for life science research and drug discovery and development. The acquisition significantly expands Thermo Fisher Scientific's leadership position in the growing RNAi field.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer.
Sign up at EasyStockAlerts.com To Be Alerted To Your Stock News Today!
Related Categories
Mergers and AcquisitionsStocks Mentioned
+6.93Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
